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The human mitochondrial transcription termination
factor (mTERF) is a nuclear-encoded 39-kDa protein
that recognizes a mtDNA segment within the mitochon-
drial tRNALeu(UUR) gene immediately adjacent to and
downstream of the 16 S rRNA gene. Binding of mTERF
to this site promotes termination of rDNA transcription.
Despite the fact that mTERF binds DNA as a monomer,
the presence in its sequence of three leucine-zipper mo-
tifs suggested the possibility of mTERF establishing in-
termolecular interactions with proteins of the same or
different type. When a mitochondrial lysate from HeLa
cells was submitted to gel filtration chromatography,
mTERF was eluted in two peaks, as detected by immu-
noblotting. The first peak, which varied in proportion
between 30 and 50%, appeared at the position expected
from the molecular mass of the monomer (41  2 kDa),
and the gel filtration fractions that contained it exhib-
ited DNA binding activity. Most interestingly, the mate-
rial in this peak had a strong stimulating activity on in
vitro transcription of the mitochondrial rDNA. The sec-
ond peak eluted at a position corresponding to an esti-
mated molecular mass of 111  5 kDa. No mTERF DNA
binding activity could be detected in the corresponding
gel filtration fractions. Therefore, we propose that
mTERF exists in mitochondria in two forms, an active
monomer and an inactive large size complex. The esti-
mated molecular weight of this complex and the fact
that purified mTERF can be eluted from a gel filtration
column as a complex of the same molecular weight
strongly suggest that this inactive complex is a homotri-
mer of mTERF.
Transcription of the heavy (H)-strand of mitochondrial DNA
involves two overlapping transcription units starting at two
closely located initiation sites in the D-loop region (1–3). One of
these transcription units produces an oligo(dT)-cellulose un-
bound RNA species (u4a) spanning the whole rDNA region, i.e.
the genes for the two mitochondrial rRNAs, 12 S and 16 S, the
tRNAPhe and the tRNAVal, and ending at the border between
the 16 S rRNA and the tRNALeu(UUR) genes (4). The other
transcription unit produces a single polycistronic oligo(dT)-
cellulose bound RNA molecule (b4), encompassing almost the
entire length of the H-strand. The u4a and b4 transcripts are
subsequently processed to yield, respectively, the two mature
rRNAs, the tRNAPhe and tRNAVal, and the H-strand encoded
other tRNAs and mRNAs. The rRNA genes are expressed at a
20–50-fold higher rate relative to the downstream genes (5, 6).
This differential expression is regulated not only at the level of
transcription initiation, but also at the level of termination at
the 3-end of the rDNA transcription unit. A central role in the
attenuation phenomenon taking place at this site is played by
the mitochondrial transcription termination factor (mTERF),1
a 39-kDa DNA-binding protein that binds to a 28-base pair
region (nucleotides 3229 to 3256) within the tRNALeu(UUR)
gene, at a position immediately adjacent to the 16 S rRNA
gene. This protein promotes transcription termination at the
3-end of the 16 S rRNA gene, as shown by an in vitro tran-
scription assay (7, 8).
The primary structure of mTERF shows some relevant fea-
tures, namely, three putative leucine-zipper motifs and two
basic potential DNA-binding domains. Both types of motifs are
essential for binding of mTERF to its DNA target sequence,
and, consequently, for promoting transcription termination (9).
Despite leucine zippers being typical protein-protein interac-
tion motifs, it has been clearly demonstrated that mTERF
binds DNA as a monomer (9). This has led to the suggestion
that mTERF acquires DNA binding activity by means of in-
tramolecular leucine-zipper interactions, required to bring the
two basic DNA-binding domains together (9).
In the present work, we have explored the possibility that
mTERF interacts with other proteins of the same or different
type when not bound to DNA, and we have found that mTERF
exists in HeLa cell mitochondrial lysates in two forms. One is a
monomeric form, exhibiting DNA binding and transcription-
termination activities, as expected from previous results (9),
whereas the other is a novel high molecular weight complex
lacking DNA binding activity. The evidence obtained has
strongly suggested that the novel complex form of mTERF is a
homotrimer. We, therefore, propose that the activity of mTERF
is modulated by the transition between an active monomer and
an inactive trimer.
EXPERIMENTAL PROCEDURES
Preparation of Polyclonal Anti-mTERF Antibody—His-tagged
mTERF expressed in Escherichia coli and purified by nickel column
chromatography, followed by SDS-PAGE, and electroelution from the
mTERF-containing excised band was used for the immunization of a
rabbit as described in Ref. 10.
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The first immunization was carried out by subcutaneous injection of
400 g of pure His-tagged mTERF dissolved in 0.6 ml of phosphate-
buffered saline, 0.1% SDS mixed with 1 volume of Complete Freund’s
adjuvant (Sigma). Subsequent immunizations were carried out by sub-
cutaneous injection of 200 g of pure His-tagged mTERF dissolved in
0.6 ml of phosphate-buffered saline, 0.1% SDS mixed with 1 volume of
incomplete Freund’s adjuvant (Sigma) 3, 7, and 11 weeks after the first
immunization. 10–30-ml blood samples were taken prior to each im-
munization and at week 15, and the animal was exanguinated by
cardiac puncture at week 20. The sera obtained were tested for the
presence of anti-mTERF antibody by enzyme-linked immunosorbent
assay (10). Antibodies were already detectable 3 weeks after the first
inoculation and reached a plateau at week 15.
Purification of mTERF from HeLa Cells—mTERF was purified from
the S-100 fraction of a HeLa cell mitochondrial Tween 20 lysate (pre-
pared from six 3-liter balloons of HeLa cell suspension cultures grown
in modified Eagle’s medium supplemented with 5% calf serum to late
exponential phase at 37 °C) by heparin chromatography followed by
DNA-affinity chromatography (using a DNA affinity resin prepared by
ligation of multiple units of a 44-mer double-stranded oligodeoxynucle-
otide carrying the binding site of mTERF (7) present within the 16 S
rRNA/tRNALeu(UUR) boundary region, followed by coupling to Sepha-
rose) essentially as described previously (11) with two minor modifi-
cations: (a) the sample was diluted with buffer A without KCl (25 mM
HEPES-KOH, pH 7.6, 5 mM MgCl2, 0.5 mM EDTA, 1 mM dithiothre-
itol, 0.2 mM phenylmethylsulfonyl fluoride, 0.1 M pepstatin A, 10%
glycerol, 0.1% Tween 20) instead of being dialyzed with buffer A
containing 100 mM KCl, prior to heparin chromatography, and (b) the
final elution from the DNA affinity column was carried out with a
step gradient of buffer B (25 mM HEPES-KOH, pH 7.8, 12.5 mM
MgCl2, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride,
0.1 M pepstatin A, 20% glycerol, 0.1% Tween 20) containing 0.35,
0.5, 0.8, and 1 M KCl.
Gel Filtration Chromatography of S-100 Fraction from a Mitochon-
drial Lysate—Gel filtration chromatography of the S-100 fraction from
a HeLa cell mitochondrial lysate was carried out on a FPLC system
(Pharmacia) in the cold room. The column used was a HiPrep®
Sephacryl S-200 (Pharmacia). For each run, the column was equili-
brated in running buffer (25 mM HEPES, pH 7.6, 5 mM MgCl2, 0.5 mM
EDTA, 1 mM dithiothreitol, 10% glycerol, 0.1% Tween 20, 150 or 500 mM
KCl) at a flow rate of 1 ml/min. A calibration curve was prepared,
following the instructions of the manufacturer of the column, by run-
ning blue dextran 2000, cytochrome c (12 kDa), ovalbumin (43 kDa),
bovine serum albumin (67 kDa), aldolase (158 kDa), and catalase (232
kDa), all from Amersham Biosciences. The elution of these markers was
monitored by UV photometry (280 nm) with the full scale set to 0.05
absorbance units, and the elution volume was measured from the
start of the sample application to the apex of the elution peak. The
logarithm of molecular weight was plotted against Kav that was
calculated for each protein as follows: Kav  Ve  Vo/Vt  Vo, where
Ve  elution volume for the protein; Vo  column void volume 
elution volume of blue dextran 2000; Vt  total bed volume (120 ml for
HiPrep® Sephacryl S-200). Prior to the injection of a sample, a set of
three markers (cytochrome c, ovalbumin, and catalase) was injected
to test the performance of the column. When the Kav of the markers
was consistent with the calibration curve, 1.5–2 ml of S-100 were
loaded into the column, and the eluate was collected in 1-ml fractions,
flash frozen in liquid nitrogen, and stored at 80 °C until further
analysis.
Analysis of the fractions by SDS-PAGE followed by immunoblotting
(12), using anti-mTERF antiserum as primary antibody, goat anti-
rabbit IgG (HL) horseradish peroxidase-linked (Promega) as second-
ary antibody, and SuperSignal® West Pico (Pierce) as chemilumines-
cent substrate, allowed the determination of the elution volume of
mTERF by autoradiography and quantification of the autoradiogram by
densitometry, and the calculation of the Kav of the mTERF as described
above. Its molecular weight was finally estimated by interpolation of its
Kav in the calibration curve.
Native Polyacrylamide Gel Electrophoresis—Native PAGE of the elu-
ates from the gel-filtration chromatography was run from anode to
cathode under acidic conditions, as described in Ref. 13. The gel con-
sisted of a 3.75% acrylamide, 0.7% acetic acid-KOH stacking gel (pH
6.8) and a 8–15% acrylamide, 2% acetic acid-KOH gradient resolving
gel (pH 4.3). The running buffer composition was 0.8% acetic acid, 0.35
M -alanine (pH 4.5). The samples were mixed with 1 volume of sample
buffer (3.4% acetic acid, 0.1 M KOH, pH 4.3, 20% glycerol, and 0.005%
methyl green), centrifuged for 1 min at 12,000  gav and loaded. The
run took place at 8 °C at 20 mA until the dye front reached the resolving
gel. Then the current was increased to 30 mA, and electrophoresis was
continued for 5–10 h.
After the run, the gel was silver stained or transferred to the poly-
vinylidene difluoride (Bio-Rad) membrane for subsequent immunoblot-
ting. The procedure for immunoblotting of the native gel was essentially
identical to that used for SDS-PAGE, except for the fact that the gel was
incubated in 0.1% SDS transfer buffer (0.1% SDS, 39 mM glycine, 48 mM
Tris base, 0.037% SDS, 20% methanol, pH 8.3) for 30 min prior
to transfer.
In Vitro Transcription and S1 Protection Assays—Transcription-ter-
mination experiments were performed in 50 concentrated gel filtra-
tion fractions essentially as described previously for S-100 from mito-
chondrial lysates (8, 11), using 0.5 g of the transcription-termination
clone pTER (Ref. 7 and Fig. 1a) as DNA template. S1 protection assays
were carried out on the RNA products of the transcription reaction
using, as a specific probe, the unlabeled RNA synthesized utilizing
BamHI-linearized pBSVM plasmid (containing the MaeI-MaeI frag-
ment of pTER (Fig. 1a)) and T3 RNA polymerase, as described (8, 11).
A scheme of the assay is shown in Fig. 1b.
Band-shift Assays—Mobility shift assays were carried out using as a
probe a 5-end 32P-labeled version of the same double stranded 44-mer
oligodeoxynucleotide used in the DNA affinity purification (7). A stand-
FIG. 1. Determination of mTERF
termination activity. a, map of the
clone pTER used as DNA template.
Shown are the initiation sites for the H-
strand rDNA transcription (IHR) and for
L-strand transcription (IL) and the termi-
nation site for rDNA transcription at the
3 end of the 16 S rRNA gene (T). b, dia-
gram of the in vitro transcription assay
and the S1 protection assay, showing the
map position of the expected transcripts
(thick arrows), the map position of the
MaeI-MaeI RNA probe (S1 probe), as well
as the map position of the expected pro-
tected products.
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ard band-shift assay reaction mixture contained 0.5 g of poly(dI-
dC)(dI-dC), previously heated at 90 °C for 5 min, 20 fmol of 5-end
32P-labeled probe, 5 g of bovine serum albumin (New England Bio-
labs), a variable volume of sample, and buffer C (25 mM HEPES, pH 7.5,
50 mM KCl, 12.5 mM MgCl2, 1 mM dithiothreitol, 20% glycerol, 0.1%
Tween 20) to a final volume of 25 l. The reaction mixture was incu-
bated at room temperature for 20 min, placed on ice, and immediately
loaded and run in a native 10% polyacrylamide gel in the cold room as
described (11). After the run, the gel was dried and analyzed by auto-
radiography. In some experiments, especially those involving a subse-
quent immunoblotting of the shifted bands, the reaction mixture was
upscaled to 100 l.
Supershift experiments were carried out as described above, except
that 1 l of anti-mTERF antiserum was included in the reaction mix-
ture. A control in which 1 l of preimmune serum was added was run
in parallel.
RESULTS
Gel Filtration Chromatography of the Mitochondrial S-100
Reveals Two Forms of mTERF—The S-100 fraction of a mito-
chondria lysate is known to contain mTERF, and it has been
used in the past as the primary source for the purification of
mTERF from HeLa cells (7). Preliminary experiments aimed at
identifying high molecular weight (HMW) forms of mTERF
involved a sedimentation of the mitochondrial S-100 from
HeLa cells through a 15–35% linear glycerol gradient (14),
using bovine liver catalase as a sedimentation marker and
SDS-PAGE followed by Western blots with anti-mTERF anti-
serum to detect the presence of mTERF. These experiments
indicated the presence of a form of mTERF having a higher
sedimentation constant than that of the monomeric form. For
further analysis of this potential HMW form of mTERF, the
S-100 fraction from HeLa cells was fractionated by gel filtra-
tion chromatography using a HiPrep® Sephacryl S-200 col-
umn. The presence of mTERF in the chromatography fractions
was revealed by SDS-PAGE, followed by Western blotting us-
ing anti-mTERF antiserum. Because mTERF is known to be
stable and dissociated from DNA at high salt concentration, gel
filtration chromatography was first carried out with a running
buffer containing 0.5 M KCl. As shown in Fig. 2, a and b,
mTERF was eluted in two peaks, the first encompassing 2⁄3
and the second 1⁄3 of the antibody-reactive material. Gel fil-
tration chromatography of the same mitochondrial S-100 prep-
aration carried out in 0.15 M KCl yielded identical results (data
not shown). In contrast, in chromatographic runs of different
mitochondrial S-100 preparations a certain variability in the
proportion of the two peaks was observed (see below). To esti-
mate the molecular weight of each form, their Kav values were
calculated and interpolated on a calibration curve previously
performed on the same column, as described under “Experi-
mental Procedures.” The molecular mass values obtained for
FIG. 2. Results of gel filtration chromatography of 1.5 ml of S-100 (corresponding to 7.5–10 mg of total protein) using a HiPrep®
Sephacryl S-200 column and 0.5 M KCl in the elution buffer. a, elution profile of mTERF determined by immunoblotting of the even fractions.
A mixture of aldolase, ovalbumin, and cytochrome c was loaded into the column prior to the injection of the mitochondrial S-100. b, actual
immunoblots used to trace the elution profile shown in a. The upper blot allowed the demonstration of the existence of the two mTERF peaks,
whereas the lower blots confirmed the absence of other peaks before or after the ones described. c, immunoblotting of a native-PAGE gel. Gel
filtration chromatography eluates 18–24 (HMW pool) and 30–36 (LMW pool) were pooled, 50 concentrated, and 25 l of each pool were mixed
with 1 volume of sample buffer (0.1 M KOH, 3.4% acetic acid, 20% glycerol, and 0.005% methyl green, pH 4.3) and loaded. Immunoblotting was
carried out as described under ‘‘Experimental Procedures.’’
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the mTERF present in the two peaks were 41  2 and 111  5
kDa (expressed as mean  S.D. of three independent experi-
ments). The estimated molecular weight of the lighter form
(LMW) closely matched that of mature mTERF (39,000), but
the other peak at 111,000 indicated that mTERF coexists in the
mitochondrial lysate as part of a HMW complex. When pooled
gel filtration fractions of each mTERF form were submitted to
native-PAGE electrophoresis from anode to cathode under
acidic conditions, as specified under “Experimental Proce-
dures,” and subsequent immunoblotting with anti-mTERF an-
tibody, a clear difference in migration was observed between
the two forms (Fig. 2c). The HMW pool showed a single band,
whereas the LMW pool showed two bands, a less intense one
migrating exactly as the HMW form, and a second one migrat-
ing clearly behind it. The presence of the faster migrating band
in the LMW pool is most probably because of a contamination
with the HMW form, whereas the slower migrating band is the
actual LMW form. The unexpected relative migration of the
two mTERF forms by native PAGE electrophoresis is com-
mented upon under “Discussion.” The relative intensity of the
HMW and LMW bands is consistent with the relative amount
of both forms observed by gel filtration chromatography (com-
pare Fig. 2, c with a).
Transcription-termination Activity Assay of Gel Filtration
Fractions—The transcription-termination activity of the two
forms of mTERF was next determined. For this purpose, the gel
filtration fractions of the two mTERF-containing eluate peaks,
that in this experiment were of approximately equal size, were
divided into 9 pools, concentrated 50-fold, and tested in an in
vitro transcription system, followed by an S1 protection assay.
As seen in Fig. 3, the monomeric form of mTERF exhibited
transcription-termination activity, as expected (9). By contrast,
the transcription-termination assay did not provide any infor-
mation about the activity of the HMW form, because in vitro
transcription was almost completely inhibited in the pooled
fractions containing this form.
Analysis of the run-off transcripts from fractions containing
the monomeric form showed that the rate of L-strand transcrip-
tion remained at the same level as that shown in the control
sample (in which no gel filtration eluate was added to the in
vitro transcription mixture), whereas the rate of H-strand tran-
scription dramatically increased (Fig. 3). These results sug-
gested that the monomeric form of mTERF may enhance H-
strand transcription from the IHR initiation site, in agreement
with previous observations (7).
Only the Monomeric Form of mTERF Has DNA Binding
Activity—Because the termination activity assays of the HMW
form of mTERF revealed complete absence of transcription in
the presence of this form, the DNA binding activity of both
mTERF forms was investigated. A band-shift assay using a
double-stranded 44-mer oligodeoxynucleotide probe containing
the mTERF DNA-binding site (7), carried out on fractions from
another gel filtration chromatography experiment (which
again yielded two peaks of mTERF-containing eluate of approx-
imately equal size), resulted in a series of shifted bands (Fig.
4a). Only two of these (indicated by arrows) were present in
fractions that contained mTERF. Fractions containing the
HMW form exhibited almost exclusively the upper one of the
two bands, whereas fractions containing the monomeric form
exhibited both bands. As this observation suggested the possi-
bility that both forms of mTERF had specific DNA binding
activity, the analysis was refined by a supershift assay carried
out on a fraction (number 27) containing both bands (Fig. 4b).
The lower one of the two bands almost disappeared when the
anti-mTERF antiserum was present in the reaction mixture,
being replaced by a slower moving band, whereas the upper
band was unaffected. In agreement with this finding, excision
of the two shifted bands from another gel fraction (number 26)
and analysis by Western blotting of the eluted proteins showed
that mTERF was indeed in the lower band, but not in the upper
one (Fig. 4c).
To confirm the previous observation, after a gel filtration
chromatography, pooled fractions containing either the mono-
meric or the HMW form of mTERF were submitted to heparin
chromatography, followed by Western blotting analysis of the
flow-through and eluted fractions (Fig. 4d). Heparin binds
FIG. 3. Transcription-termination activity assays. a, elution pro-
file of mTERF from the gel filtration of the mitochondrial S-100. Nine
5-ml fractions were collected, 50 concentrated, and analyzed by SDS-
PAGE and immunoblotting using anti-mTERF antiserum. b, 32P-la-
beled products from an in vitro transcription assay of each fraction were
run on a 5% acrylamide, 7 M urea gel. H, H-strand runoff transcript; L,
L-strand runoff transcript; T, H-strand terminated transcript. c, S1
protection products of the same fractions, run on a 5% acrylamide, 7 M
urea gel. H, H-strand runoff transcript; T, terminated transcript. d,
quantification by densitometry of the autoradiogram obtained from the
products of in vitro transcription assays shown in b. Ctrl, control sam-
ple, in which the in vitro transcription reaction was run in the absence
of any added gel filtration fraction. MW, molecular weight markers:
100-bp DNA ladder, from New England Biolabs.
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DNA-binding proteins non-specifically, and is a commonly used
first step in the purification of DNA-binding proteins (15). The
monomeric form of mTERF showed the typical behavior of a
DNA-binding protein. Although a small proportion was present
in the flow-through (most probably because of saturation of the
resin, or to the presence of a small amount of HMW-mTERF in
the LMW pool), most of the mTERF started to be eluted from
the column at 0.5 M KCl. In contrast, when the HMW mTERF-
containing pooled fractions were loaded onto the heparin col-
umn, all the mTERF was present in the flow-through, and none
was detected in the eluates. From the band-shift and supershift
assays and from the Western blotting and heparin chromatog-
raphy experiments, we conclude that only the monomeric form
of mTERF has DNA binding activity, and that the protein(s)
responsible for the upper one of the doublet of shifted bands in
Fig. 4a is unrelated to mTERF.
Pure mTERF Is Eluted as a HMW Form from the Gel Filtra-
tion Column—mTERF from HeLa cells can be purified to a high
degree by heparin chromatography followed by DNA-affinity
chromatography (7). As shown in Fig. 5a, only a pair of low
molecular mass contaminants co-purify with the two “34-kDa”
mTERF bands (8, 9) under these conditions. When the 0.8 M
KCl eluate from the DNA affinity column was submitted to gel
filtration chromatography, mTERF was eluted completely as
the previously identified HMW form, whereas the contaminat-
ing bands were eluted in the first fractions, totally separated
from mTERF. The observation that pure mTERF was eluted
completely from a gel filtration column as the HMW form
FIG. 4. DNA binding assays. a, band-shift assay of fractions from a gel filtration chromatography. Upper half, elution profile of mTERF, as
assessed by SDS-PAGE of the odd gel filtration fractions, followed by immunoblotting using anti-mTERF antiserum. Lower half, the even fractions
from the same experiment were submitted to band-shift assay as described under ‘‘Experimental Procedures.’’ The arrows on the right of the
autoradiography mark the two shifted bands of interest. b, supershift assay. 1, probe only. 2, fraction 27 from the gel filtration experiment shown
in a. 3, fraction 27 in the presence of preimmune serum. 4, fraction 27 in the presence of anti-mTERF antiserum. The thick black arrows on the
right of the autoradiogram indicate the disappearance of the lower shifted band and the appearance of a new, supershifted band when the
anti-mTERF antibody is present in the band-shift assay. c, immunoblotting, using anti-mTERF antiserum, of the proteins eluted from the excised
bands shown in b and run on an SDS-PAGE in parallel with pure mTERF. Only the lower shifted band shows the presence of mTERF. d,
SDS-PAGE followed by immunoblotting of the flow-through (F) and eluates (0.3 M through 3.0 M KCl) from heparin chromatography of the HMW
and LMW pools, showing that only the LMW form of mTERF binds to heparin.
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without trace of the monomer form was unexpected, because
the DNA affinity chromatography following heparin chroma-
tography was the previously used approach to purify active
mTERF. This question is discussed below.
DISCUSSION
mTERF is known to bind to DNA as a monomer (9). This led
to the proposal that intramolecular interactions between the
leucine-zipper motifs were required to bring the two basic
domains in close register with the mTERF target DNA se-
quence. This is in contrast with most leucine-zipper proteins,
which use their leucine-zipper domains to interact with other
proteins. Many of them, like C/EBP, GCN4, c-Fos, and c-Jun
are transcription factors like mTERF, and the formation of
homo- or heteropolymers regulates their DNA binding activity
(16, 17). It was in this context that we decided to explore
whether mTERF can form homopolymeric or heteropolymeric
complexes with possible regulatory roles.
In the present work, no difference was observed in the sep-
aration by gel filtration chromatography of the monomeric form
of mTERF and of a complex roughly three times bigger than the
monomer, or in their proportion, when high (0.5 M) or low (0.15
M) concentrations of KCl were used during the chromatogra-
phy. The stability of the HMW form of mTERF at high ionic
strength may be indicative of the fact that electrostatic inter-
actions are not essential for the formation of such a structure.
In fact, the interaction between leucine-zipper domains is ba-
sically maintained by the interaction of the hydrophobic resi-
dues at positions a and d of the heptad repeats (the residues of
the heptad being designated as a–g (17, 18)), and the stabiliz-
ing role of the electrostatic interactions between residues in
positions e and g described in some cases is far from being
general (19, 20). This interpretation is in accordance with the
paucity of charged residues in the leucine-zipper domains of
mTERF (6 polar residues of 15 at position e, and only 2 of 15 at
position g) (9).
In vitro transcription experiments clearly showed the ex-
pected transcription-termination activity associated with the
monomeric form. Surprisingly, however, transcription of both
strands was inhibited in the fractions containing the HMW
form. Further work is needed to identify the factor(s) causing
this effect. It cannot be ruled out that mTERF itself, in its
trimeric form, is responsible for the inhibition of transcription
initiation. However, transcription experiments carried out with
the DNA affinity purified mTERF (which behaved like a trimer
in gel filtration chromatography) showed no effect on transcrip-
tion initiation. Other proteins present in the gel filtration frac-
tions might be responsible for the effect on initiation of tran-
scription. Another surprising result of the in vitro transcription
experiments was that the termination activity observed in the
fractions containing the monomer was accompanied by a strik-
ingly increased rate of H-strand transcription from the rDNA
initiation site (IHR). If it is confirmed that the monomeric form
of mTERF is responsible for both the termination activity and
the stimulation of transcription initiation, the ideas about the
mechanism whereby mTERF exerts control of rDNA transcrip-
tion will have to be revised, and a broader role for mTERF will
have to be considered. This role is reminiscent of that described
for TTF-I, a protein that promotes transcription termination of
the nuclear rRNA genes in mammals (21, 22). TTF-I-mediated
termination is accompanied by an increase in initiation be-
cause of facilitation of reinitiation after RNA polymerase re-
lease from the termination site (23). This mechanism may also
apply to mTERF. However, the possibility that the DNA car-
rying the rDNA transcription unit forms a loop that brings
FIG. 5. DNA affinity purified mTERF from HeLa cells is eluted from a gel filtration chromatography column essentially as the
HMW form. a, silver-stained SDS-PAGE gel showing the 0.5 and 0.8 M KCl eluate from a DNA affinity purification (molecular weight marker:
High-Range RainbowTM, from Amersham Biosciences). b, elution profile of mTERF from a gel filtration chromatography column of 0.5 ml of the
0.8 M KCl DNA affinity chromatography eluate (shown in a). c, actual silver-stained SDS-PAGE gel of the fractions from the gel filtration
chromatography used to plot the elution profile of mTERF shown in b.
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promoter and termination elements in close contact, so that the
RNA polymerase is “handed over” from the termination to the
initiation sites, as initially proposed for TTF-I (24), cannot be
ruled out. Furthermore, it is also possible that mTERF inter-
acts directly with the H-strand promoter, activating it.
From the in vitro transcription experiments it was not pos-
sible to obtain any information about the transcription-termi-
nation activity of the HMW form. However, the band-shift
experiments, the Western blot analysis of the excised shifted
bands, and the heparin chromatography assays showed clearly
that the monomeric form, but not the HMW form of mTERF,
had DNA binding activity. Therefore, it can be concluded that
only the monomer has transcription-termination activity, and
that the formation of the HMW form blocks DNA binding. In
the present work, binding of the HMW form to other mtDNA
sequences, besides the segment containing the only known
binding site of human mTERF within the tRNALeu(UUR) gene,
was not tested. However, the capacity of the HMW or LMW
forms to bind to other mtDNA sites is definitely an important
question for future investigations. This is especially true in
view of the evidence presented here that suggests a possible
role of mTERF in the control of the initiation of rDNA
transcription.
Two pieces of evidence strongly suggest that the polymer is a
homotrimer. First, the estimated molecular weight of the HMW
form (111,000) corresponds closely to three times the molecular
weight of mTERF (3  39,000  117,000). Second, mTERF
highly purified from HeLa cells by heparin chromatography
followed by DNA affinity chromatography could be eluted from
the gel filtration chromatography column at the same position
as the HMW mTERF form (Fig. 5). There are two well docu-
mented examples of leucine-zipper proteins whose activity is
controlled by homotrimerization. These are the heat shock
transcription factor (25) and the influenza virus hemagglutinin
(26, 27). In both cases, the interaction between the three
polypeptides, which is required for activity, is established
through their leucine zippers, which form a triple coiled-coil
structure. mTERF, however, would be unique, in the sense that
its activity is associated with the monomeric form. In this
context, it may seem paradoxical that the HMW form migrated
faster than the LMW form in a native PAGE run, because, in
principle, the mass/charge ratio of the two forms should be the
same if the HMW form is a homotrimer. Indeed, as discussed
above, no difference was observed in the ratio of the polymeric
to the monomeric form in gel filtration chromatography runs
made at 0.5 and 0.15 M KCl. However, the change in secondary
and tertiary structure associated with the transition between
the two forms might well be accompanied by a differential
exposure of other charged residues (not involved in the inter-
action between the leucine zippers) on the surface of the pro-
tein. Hypothetically, changes in shape might also contribute to
the paradoxical phenomenon observed. An answer to this issue
will require an analysis of a high resolution structure of the two
mTERF forms.
In the present work, no evidence was obtained for the exist-
ence of a heteropolymeric form of mTERF in the S-100 fraction
of a mitochondrial lysate from HeLa cells. However, this neg-
ative result does not rule out the possibility of mTERF estab-
lishing transient interactions with other proteins. This is a
very important point that will require further investigation.
The results of the gel filtration of DNA affinity purified
mTERF (Fig. 5) were in a certain sense unexpected, and gave
an idea of the complexity of this protein. In fact, the observa-
tion that virtually all mTERF migrated as an inactive polymer
(transcription-termination experiments carried out on these
fractions showed no activity; data not shown) contrasted with
previously published experiments in which substantial tran-
scription-termination activity was detected in purified frac-
tions obtained under the same conditions (7, 8). Heat shock
transcription factor 1, a leucine-zipper protein with high struc-
tural similarities with mTERF, is known to show a high tend-
ency to trimerize spontaneously during purification (28), in a
concentration-dependent manner (29). It is therefore not sur-
prising that mTERF also shows a high spontaneous tendency
to polymerize. The very elaborate protocol used for purification
by DNA affinity chromatography of mTERF indeed offers am-
ple opportunities for its polymerization. This phenomenon was
presumably not identified before because of the impossibility of
detecting inactive mTERF, because of the lack of anti-mTERF
antibody. Moreover, because the HMW form is unable to bind
to either heparin or the 44-mer double-stranded oligode-
oxynucleotide used in the DNA affinity chromatography, the
polymers detected in the last step of the purification must have
been formed after the DNA affinity chromatography. Accord-
ingly, the following sequence of events can be envisaged. Hep-
arin chromatography eliminates all the HMW form originally
present in the S-100, while concentrating the monomer. This
concentration would enhance the polymerization of a fraction of
the monomeric form, which would be lost during the DNA
affinity step. The remaining pure monomeric form would have
a very strong tendency to polymerize, because of high concen-
tration and high purity. The substantial unexplained differ-
ences in the mTERF termination activity observed in previous
studies (7, 8) suggest that this phenomenon was indeed also
happening in the earlier work. On the other hand, also in the
present work a certain variability was observed from experi-
ment to experiment in the proportion of mTERF in the S-100
that was in the monomeric form, this proportion varied be-
tween 30 and 50%. Differences in the initial concentration
of cells, length of culture, cell homogenization conditions, to
mention just a few of the possible variables, might expose
mTERF to different levels of proteases, or other unidentified
factors that influence the stability of either form, causing the
variability observed. Another possible cause of this variability
is the presence of mtDNA contaminating the S-100, which may
favor the presence of the monomeric form. It is obvious that
further work is necessary to understand the variables control-
ling the proportions of the monomeric or HMW forms of
mTERF in different experiments. However, it seems clear that
pure mTERF can be eluted from the gel filtration column at the
position of the HMW form, and this observation provides a very
strong indication that the HMW form is indeed a homopolymer
of mTERF.
Fernandez-Silva and colleagues (9) proposed that the leucine
zippers of mTERF form a triple coiled-coil structure that brings
the two basic domains in close register with its target DNA
sequence. Some examples of leucine zippers establishing in-
tramolecular interactions had previously been described, like
spectrin (30) and seryl-tRNA synthetase (31). In view of the
results obtained in the present work, we now extend this hy-
pothesis, proposing that a rearrangement in the interaction
between leucine zippers is responsible for the control of the
activity of mTERF. The tertiary structure of the active mono-
mer would be maintained by intramolecular interactions,
whereas that of the inactive HMW form, in the form of a
homotrimer, would depend on intermolecular interactions.
Although the work described in this paper has extended our
knowledge on the role of mTERF in the regulation of transcrip-
tion of the mitochondrial rDNA, it is clear that numerous
critical questions have been raised by the results obtained.
Does the mTERF trimer have a function, or is it a means for
controlling the amount of active mTERF monomer in the mi-
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tochondrial matrix? Is there a physiological mechanism con-
trolling the formation of the trimer and its conversion back to
monomer? How much trimer is normally occurring in vivo?
Future work will be aimed at assessing the in vivo relevance of
our findings, at studying the molecular mechanism responsible
for the transition between the active mTERF monomer and the
inactive trimer, as well as at dissecting the putative role of
mTERF in the control of transcription initiation.
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